你即將離開本站

並前往https://www.healio.com/news/endocrinology/20210629/surpass-data-impressive-tirzepatide-could-change-goals-for-diabetes-treatment

SURPASS data: 'Impressive' tirzepatide could change goals ...

“SURPASS-3 is the first study comparing efficacy and safety of a dual GIP/GLP-1 receptor agonist with a basal insulin in patients failing ...

確定！ 回上一頁

查詢 「SURPASS study」的人也找了：

  1. SURPASS study
    2.
  2. Tirzepatide
    3.
  3. SURPASS-3 tirzepatide
    4.
  4. SURPASS 4 tirzepatide
    5.
  5. Tirzepatide lancet
    6.
  6. Tirzepatide a potential new agent for type 2 diabetes
    7.
  7. SURPASS-CVOT
    8.
  8. Tirzepatide FDA
    9.